tiprankstipranks
Haemonetics Corp. (HAE)
NYSE:HAE
US Market
HAE
Haemonetics
RESEARCH TOOLSreports
Want to see HAE full AI Analyst Report?

Haemonetics (HAE) Ownership - Who Owns Haemonetics?

442 Followers

Haemonetics (HAE) Ownership Overview

1.82%38.40%24.15%28.41%7.21%
1.82% Insiders
38.40% Mutual Funds
24.15% Other Institutional Investors
28.41% ETFs
7.21% Public Companies and
Individual Investors
The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 90.96% of the company’s stock is owned by Institutional Investors, 1.82% is owned by Insiders, and 7.21% is owned by Public Companies and Individual Investors.
The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 62.55% of the company’s stock is owned by Institutional Investors, 1.82% is owned by Insiders, and 28.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 12, 2025
Mark Kroll
xxxxxxxxxxxxx
$98784
Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
Bridgewater Associates, Lp
xxxxxxxxxxxxx
$4479975
Jun 30, 2026
Ariel Investments Llc
xxxxxxxxxxxxx
$154572450
Jun 30, 2026
Graham Capital Management, L.p.
xxxxxxxxxxxxx
$207750
Jun 30, 2026
Blackstone Inc.
xxxxxxxxxxxxx
$620100
Show More Hedge Fund Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,369,354Institution11.80%552,613,914
4,254,858Institution9.35%437,909,985
3,753,193Institution8.25%386,278,624
3,719,710Institution8.18%382,832,553
John Rogers
2,060,966Institution4.53%212,114,621
1,068,305Institution2.35%109,949,951
972,988Institution2.14%100,139,925
865,250Institution1.90%89,051,530
Ken Fisher
662,504Institution1.46%68,184,912
640,201Institution1.41%65,889,487

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,753,193Institution8.25%386,278,624
3,719,710Institution8.18%382,832,553
972,988Institution2.14%100,139,925
865,250Institution1.90%89,051,530
640,201Institution1.41%65,889,487
639,350Institution1.41%65,801,902
612,960Institution1.35%63,085,843
506,987Institution1.11%52,179,102
363,531Institution0.80%37,414,611
345,956Institution0.76%35,605,792

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
iShares
1,627,851Institution3.58%167,538,425
iShares
1,567,099Institution3.44%121,152,424
Vanguard
1,447,193Institution3.18%123,792,889
iShares
1,207,675Institution2.65%124,293,911
Vanguard
1,042,525Institution2.29%78,189,375
Vanguard
535,269Institution1.18%45,786,910
iShares
410,316Institution0.90%42,229,723
SPDR
345,675Institution0.76%35,576,871
Vanguard
331,783Institution0.73%28,380,718
Vanguard
301,974Institution0.66%25,830,856

FAQ

Who Owns Haemonetics Corp. (HAE)?
According to the latest TipRanks data, approximately 24.15% of the company's stock is held by institutional investors, 1.82% is held by insiders, and 7.21% is held by retail investors.
    What percentage of Haemonetics Corp. (HAE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 24.15% of Haemonetics Corp. (HAE) stock is held by institutional investors.
      What percentage of Haemonetics Corp. (HAE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 7.21% of Haemonetics Corp. (HAE) stock is held by retail investors.
        Who owns the most shares of Haemonetics Corp. (HAE)?
        iShares owns the most shares of Haemonetics Corp. (HAE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.